Загрузка...
Clinical trial of clarithromycin for lepromatous leprosy.
Clarithromycin was administered to nine previously untreated lepromatous leprosy patients. Patients received two 1,500-mg doses on the first day, followed by 7 days of no treatment, in order to evaluate the potential efficacy of intermittent therapy. Patients then received 1,000 mg daily for 2 weeks...
Сохранить в:
| Главные авторы: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
1994
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC284490/ https://ncbi.nlm.nih.gov/pubmed/8203847 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|